Evidence map›Paper›PMID 30142143›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2018

Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation.

Thibaut Davy-Mendez, Sonia Napravnik, Oksana Zakharova, JoAnn Kuruc, Cynthia Gay, Charles B Hicks, Kara S Mcgee, Joseph J Eron

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Trajectories of CD4Viruses · 2022
    Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Immunomodulatory Effect of a New Ingredients Group Extracted fromDrug design, development and therapy · 2021
    Article
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Thibaut Davy-MendezDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Sonia NapravnikDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Oksana ZakharovaDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC.
JoAnn KurucDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Cynthia GayDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Charles B HicksDivision of Infectious Diseases, University of California San Diego, La Jolla, CA.
Kara S McgeeDivision of Infectious Diseases, Duke University Medical Center, Durham, NC.
Joseph J EronDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Training in Sexually Transmitted Infections and HIVT32AI007001 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SENA-SOBERANO, ARLENE C. · 1985 to 2025
$10.9M
NIAID NIH HHS P30 AI050410NIAID NIH HHS T32 AI007001
6 · The paper itself

Abstract

backgroundWe estimated the effect of initiating virologically suppressive antiretroviral therapy (ART) during acute HIV infection versus chronic HIV infection (AHI vs. CHI) on CD4/CD8 ratio normalization.

settingA prospective clinical cohort study.

methodsWe included patients initiating ART with AHI and CHI between 2000 and 2015 and compared time from ART initiation to the first normal CD4/CD8 ratio (defined as CD4/CD8 ≥1) using Kaplan-Meier curves and multivariable Cox proportional hazards models. Patient time was censored at virologic failure, lost to follow-up, or death. We also characterized CD4, CD8, and CD4/CD8 trajectories over the first 3 years of ART.

resultsThe 1198 patients were 27% female and 60% African American, with a median age of 37 years (interquartile range 28-47) at ART initiation. The 83 AHI patients were more likely male, younger, and of white race, than CHI patients. After 2 years of suppressive ART, 70% of AHI patients achieved a normal CD4/CD8 ratio, compared to 6%-38% of CHI patients, with greater likelihood of normalization at higher baseline CD4 counts. Time to normalization was shortest among AHI patients, followed by CHI patients with higher baseline CD4. The adjusted hazard ratio for time to normalization for AHI patients compared to CHI patients with baseline CD4 >350 was 4.33 (95% CI: 3.16 to 5.93). Higher baseline CD4/CD8 ratio was also associated with time to normalization (adjusted hazard ratio 1.54; 1.46, 1.63, per 0.1 increase in ratio).

conclusionsInitiating ART during AHI at higher baseline CD4 cell counts and CD4/CD8 ratios was associated with shorter time to CD4/CD8 ratio normalization.

Indexed as

CD4-CD8 RatioAdultAnti-Retroviral AgentsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCohort StudiesFemaleHIV InfectionsHumansMaleMiddle AgedProspective StudiesTime FactorsTreatment OutcomeYoung AdultAnti-Retroviral Agents

Identifiers

PMID30142143
PMCPMC6203616

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.